Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nuwellis (NUWE) EBITDA (2016 - 2025)

Nuwellis filings provide 14 years of EBITDA readings, the most recent being -$2.4 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 60.65% to -$2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$17.5 million, a 56.22% decrease, with the full-year FY2025 number at -$17.5 million, down 56.21% from a year prior.
  • EBITDA hit -$2.4 million in Q4 2025 for Nuwellis, down from $467000.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $2.4 million in Q3 2024 to a low of -$12.6 million in Q2 2025.
  • Median EBITDA over the past 5 years was -$4.3 million (2021), compared with a mean of -$4.1 million.
  • Biggest five-year swings in EBITDA: crashed 205.48% in 2023 and later skyrocketed 169.85% in 2024.
  • Nuwellis' EBITDA stood at -$4.4 million in 2021, then skyrocketed by 58.12% to -$1.8 million in 2022, then crashed by 205.48% to -$5.6 million in 2023, then surged by 73.64% to -$1.5 million in 2024, then crashed by 60.65% to -$2.4 million in 2025.
  • The last three reported values for EBITDA were -$2.4 million (Q4 2025), $467000.0 (Q3 2025), and -$12.6 million (Q2 2025) per Business Quant data.